Ryan D. Lake
2019 - Recro Pharma
In 2019, Ryan D. Lake earned a total compensation of $1.5M as Chief Financial Officer at Recro Pharma.
Compensation breakdown
| Bonus | $69,440 |
|---|---|
| Non-Equity Incentive Plan | $138,880 |
| Option Awards | $334,200 |
| Salary | $319,777 |
| Stock Awards | $623,276 |
| Other | $44,038 |
| Total | $1,529,611 |
Lake received $623.3K in stock awards, accounting for 41% of the total pay in 2019.
Lake also received $69.4K in bonus, $138.9K in non-equity incentive plan, $334.2K in option awards, $319.8K in salary and $44K in other compensation.
Rankings
In 2019, Ryan D. Lake's compensation ranked 7,222nd out of 13,971 executives tracked by ExecPay. In other words, Lake earned more than 48.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,222 out of 13,971 | 48th |
Division Manufacturing | 2,780 out of 5,695 | 51st |
Major group Chemicals And Allied Products | 1,034 out of 2,194 | 53rd |
Industry group Drugs | 879 out of 1,880 | 53rd |
Industry Pharmaceutical Preparations | 650 out of 1,392 | 53rd |
Source: SEC filing on March 25, 2021.
Lake's colleagues
We found three more compensation records of executives who worked with Ryan D. Lake at Recro Pharma in 2019.
News
Recro Pharma CEO J Enloe's 2022 pay jumps 107% to $2.3M
April 6, 2023
Recro Pharma CFO Ryan Lake's 2021 pay jumps 622% to $2.3M
April 1, 2022
Recro Pharma CFO Ryan Lake's 2020 pay jumps 161% to $2.2M
March 25, 2021
Baudax Bio CEO Gerri Henwood's 2020 pay falls 87% to $603K
March 11, 2021
Recro Pharma CEO Gerri Henwood's 2019 pay jumps 90% to $4.6M
March 27, 2020